- Home
- DEC vs NVCR Comparison
DEC vs NVCR Comparison
Compare DEC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEC
- NVCR
- Stock Information
- Founded
- DEC 2001
- NVCR 2000
- Country
- DEC United States
- NVCR Switzerland
- Employees
- DEC N/A
- NVCR N/A
- Industry
- DEC
- NVCR Medical/Dental Instruments
- Sector
- DEC
- NVCR Health Care
- Exchange
- DEC Nasdaq
- NVCR Nasdaq
- Market Cap
- DEC 1.2B
- NVCR 1.4B
- IPO Year
- DEC N/A
- NVCR 2015
- Fundamental
- Price
- DEC $13.69
- NVCR $14.66
- Analyst Decision
- DEC Strong Buy
- NVCR Buy
- Analyst Count
- DEC 4
- NVCR 7
- Target Price
- DEC $22.25
- NVCR $28.79
- AVG Volume (30 Days)
- DEC 631.9K
- NVCR 1.9M
- Earning Date
- DEC 01-01-0001
- NVCR 10-30-2025
- Dividend Yield
- DEC 5.93%
- NVCR N/A
- EPS Growth
- DEC N/A
- NVCR N/A
- EPS
- DEC N/A
- NVCR N/A
- Revenue
- DEC $1,148,432,000.00
- NVCR $630,160,000.00
- Revenue This Year
- DEC $128.52
- NVCR $6.68
- Revenue Next Year
- DEC $0.46
- NVCR $7.01
- P/E Ratio
- DEC N/A
- NVCR N/A
- Revenue Growth
- DEC 64.19
- NVCR 14.58
- 52 Week Low
- DEC $10.08
- NVCR $10.87
- 52 Week High
- DEC $17.70
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- DEC 34.65
- NVCR 72.10
- Support Level
- DEC $13.86
- NVCR $12.61
- Resistance Level
- DEC $14.12
- NVCR $14.17
- Average True Range (ATR)
- DEC 0.29
- NVCR 0.54
- MACD
- DEC -0.07
- NVCR 0.20
- Stochastic Oscillator
- DEC 4.11
- NVCR 98.65
About DEC Diversified Energy Company plc
Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.